CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis.

Fatemeh SafariSafar FarajniyaMaryam AryaHabib ZarredarAva Nasrolahi

Published in: Immunopharmacology and immunotoxicology (2018)

The present paper discusses RA pathogenesis and the potential application of new developments in CRISPR-mediated Treg genome editing in personalized therapy of RA.

Keyphrases

genome editing
crispr cas
rheumatoid arthritis
disease activity
genome wide
interstitial lung disease
dna methylation
mesenchymal stem cells
risk assessment